Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after int...

por Wang, Luo, Mou, Haibo, Hou, Xuehua, Liao, Qin
Publicado 2023

CircRNA_100395 Carried by Exosomes From Adipose-Derived Mesenchymal Stem Cells Inhibits the Malignant Transformation of Non-Small Cell Lung Carcinoma Through the miR-141-3p-LATS2 A...

por Zhang, Chong, Cao, Jinlin, Lv, Wang, Mou, Haibo
Publicado 2021

Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature

por Peng, Ling, Zhou, Yun, Wang, Yina, Mou, Haibo, Zhao, Qiong
Publicado 2013

Complete remission of platinum-refractory primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature

por XU, QIUYI, XU, NONG, FANG, WEIJIA, ZHAO, PENG, MAO, CHENYU, ZHENG, YULONG, MOU, HAIBO
Publicado 2013

Case report: Long-term clinical benefit of pyrotinib therapy following trastuzumab resistance in HER2-amplification recurrent mucinous ovarian carcinoma

por Fang, Xiangming, Mou, Haibo, Ying, Xinxin, Hou, Xuehua, Wang, Luo, Wu, Ying, Yan, Naimeng, Guo, Lijie, Liao, Qin
Publicado 2022

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report

por Mou, Haibo, Yu, Lanfang, Liao, Qin, Hou, Xuehua, Wu, Yinfang, Cui, Qiang, Yan, Na, Ma, Ruobing, Wang, Lingjian, Yao, Ming, Wang, Kai
Publicado 2018

Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics

por Mou, Haibo, Yang, Qiu‐an, Yu, Lanfang, Wang, Ting, Liu, Kui, Shen, Rong, Pan, Xuedong, Dai, Yi, Wan, Qing, Zhou, Fangling, Qian, Lili, Chen, Donglin, Yau, Thomas, Dong, Xiaowei, Wang, Xuemei, Wang, Shuang
Publicado 2021

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response

por Li, Jingjing, Wei, Qing, Wu, Xiaoying, Sima, Jun, Xu, Qi, Wu, Mengmeng, Wang, Fufeng, Mou, Haibo, Hu, Hanguang, Zhao, Jianguo, Li, Da, Hu, Jinlin, Zhang, Lingnan, Zhu, Xiu, Chen, Lei, Luo, Cong, Yan, Junrong, He, Jiachen, Ma, Yutong, Shao, Yang, Wu, Wei, Ying, Jieer
Publicado 2020